Litak®
(2 mg/ml, Cladribine, 2-chloro-2'-deoxyadenosine, 2-CdA)
Cladribine is an antineoplastic agent of the following pharmacotherapeutic group: antineoplastic agents, antimetabolites, purine analogues (ATC-Code: L01BB04).
Litak® is a solution for injection that contains the active substance cladribine to treat rare forms of leukemia or lymphoma.